Perfil de resistencia microbiológico en ciudados intensivos adultos en la fundación Santa Fe de Bogotá año 2014
| Contribuinte(s) |
Celis Rodriguez, Edgar Carrizosa, Jorge Armando |
|---|---|
| Data(s) |
04/06/2015
|
| Resumo |
Se realizó un estudio descriptivo, retrospectivo; se usó la base de datos de los aislamientos microbiológicos documentados en las UCI de la Fundación Santa fe de Bogotá para el año 2014. La prevalencia de bacterias resistentes en los aislamientos de la FSFB no es baja, por lo que se requiere una terapia empírica acertada acorde con la flora local. Se requieren estudios analíticos para evaluar factores asociados al desarrollo de gérmenes multi resistentes y mortalidad por sepsis The incidence of bacteremia was 39%, the diagnosis of sepsis, severe sepsis and septic shock was overall from 50%, the most frequently isolated microorganisms were gram negative bacteria (44, 5%), followed by Candida species (37.5%) and gram negative (18%). 91% of patients received antibiotic therapy empirically, and this management strategy was adjusted with culture results in 57% of cases, most of these received combination therapy (63%). The empirical use of carbapenems was 36%, while that of cephalosporins third and fourth generation was 14.8%. Different resistance patterns usual were found in 31% of the isolates, mainly AmpC (17.6%) and ESBL (12%). ICU mortality was 30%. |
| Formato |
application/pdf |
| Identificador | |
| Idioma(s) |
spa |
| Publicador |
Facultad de Medicina |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
instname:Universidad del Rosario reponame:Repositorio Institucional EdocUR Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public health reports 2007;122(2):160. Karlsson S, Varpula M, Ruokonen E, Pettil+ñ V, Parviainen I, Ala-Kokko TI, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive care medicine 2007;33(3):435-43 Zahorec R, Firment J, Strakova J, Mikula J, Malik P, Novak I, et al. Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection 2005;33(3):122-8 Infectious Diseases Society of America. Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates--a Public Health Crisis Brews. 2004. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American journal of infection control 2004;32(8):470 Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Annals of clinical microbiology and antimicrobials 2006;5(1):2. Huang SS, Rifas-Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. Journal of Infectious Diseases 2007;195(3):330-8 Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. Journal of clinical microbiology 2007;45(10):3352-9. Goossens H, Grabein B+. Prevalence and antimicrobial susceptibility data for extended-spectrum +¦-lactamaseGÇôand AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997GÇô2004). Diagnostic microbiology and infectious disease 2005;53(4):257-64 Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997GÇô1999). Clinical Infectious Diseases 2001;32(Supplement 2):S104-S113 Weinstein RA, Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clinical Infectious Diseases 2005;41(6):848-54 Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clinical Infectious Diseases 2007;44(6):867-73. Stratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit: practical application and clinical utility. Clinical therapeutics 1992;15:12-20. Binkley S, Fishman NO, LaRosa LA, Marr AM, Nachamkin I, Wordell D, et al. Comparison of Unit-Specific and Hospital-Wide Antibiograms Potential Implications for Selection of Empirical Antimicrobial Therapy. Infection Control 2006;27(07):682-7. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive care medicine 2002;28(2):108-21. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive care medicine 2007;33(4):606-18. Silva Ez, Pedro MA, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian sepsis epidemiological study (BASES study). Critical Care 2004;8(4):R251. Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China*. Critical care medicine 2007;35(11):2538-46 Degoricija V, Sharma M, Legac A, Gradi+íer M, +áefer S, Vu-ìi-ìevi-ç +e. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. Croatian medical journal 2006;47(3):385-97. Markogiannakis H, Pachylaki N, Samara E, Kalderi M, Minettou M, Toutouza M, et al. Infections in a surgical intensive care unit of a university hospital in Greece. International Journal of Infectious Diseases 2009;13(2):145-53 Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study*. Critical care medicine 2006;34(2):344-53. Tanriover MD, Guven GS, Sen D, Unal S, Uzun O. Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country. Epidemiology and infection 2006;134(02):315-22. Molina FJ, D+¡az CA, Barrera L, De La Rosa G, Dennis R, Due+¦as C, et al. Perfil microbiol+¦gico de la Infecciones en Unidades de Cuidados Intensivos de Colombia (EPISEPSIS Colombia). Medicina Intensiva 2011;35(2):75-83. Mart+¡nez Buitrago E, Hern+índez C, Pallares C, Pacheco R, Hurtado K, Recalde M+. Frecuencia de aislamientos microbiol+¦gicos y perfil de resistencia bacteriana en 13 cl+¡nicas y hospitales de alta complejidad en Santiago de Cali-Colombia. Infectio 2014;18(1):3-11. Mateus JE, Le+¦n FJ, Gonz+ílez GM, Narv+íez EX. Resistencia a los antibi+¦ticos en dos unidades de cuidados intensivos de Bucaramanga (Colombia). Salud & Sociedad 2014;1(1). Appleby DH, John Jr JF. Use, misuse, and cost of parenteral cephalosporins at a county hospital. Southern medical journal 1980;73(11):1473-5. Jogerst GJ, Dippe SE. Antibiotic use among medical specialties in a community hospital. Jama 1981;245(8):842-6 Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clinical Infectious Diseases 2003;36(1):53-9. Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infection Control 2003;24(09):690-8 Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infection Control 2003;24(04):251-6. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive care medicine 2001;27(2):355-62. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. CHEST Journal 2002;122(1):262-8. Leone M, Bourgoin Al, Cambon S, Dubuc M, Alban+¿se J, Martin C. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome*. Critical care medicine 2003;31(2):462-7. Grupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bacteremia. Infection Control 2007;28(03):293-8. Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. American journal of respiratory and critical care medicine 1997;156(1):196-200 Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. CHEST Journal 1998;113(2):412-20. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, El-Ebiary M, Carrillo A, Ruiz J, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. American journal of respiratory and critical care medicine 1998;157(2):371-6. Alvarez-Lerma F, ICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive care medicine 1996;22(5):387-94. Camargo R, Zuluaga I, Mar+¡n A, Salcedo S, Niebles J, Hern+índez M, et al. Valoraci+¦n diaria de la prescripci+¦n de antibi+¦ticos en una instituci+¦n de salud y su impacto en la resistencia a bacterias Gram negativas en cuidados intensivos. Acta Colombiana de Cuidado Intensivo 2008;8(4):293-301. TEME |
| Palavras-Chave | #615.1 #Resistencia medicamentos #Infección hospitalaria #Cuidados intensivos #Monitoreo epidemiológico #Agentes antibacterianos #Drug Resistance #Intensive care #Sensivity microbial tests #Epidemiological Monitoring #Sepsis |
| Tipo |
info:eu-repo/semantics/bachelorThesis info:eu-repo/semantics/acceptedVersion |
